Viewing Study NCT00453427


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
Study NCT ID: NCT00453427
Status: COMPLETED
Last Update Posted: 2015-06-03
First Post: 2007-03-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
Sponsor: Ontario Clinical Oncology Group (OCOG)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module